Doi.org/10.3324/haematol.2015.126672
Jump to navigation
Jump to search
Target Article[edit | edit source]
Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib; Lipsky AH, Farooqui MZ, Tian X, et al.; Haematologica; 2015; https://doi.org/10.3324/haematol.2015.126672
Article providing comments[edit | edit source]
Comment on Lipsky et al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib; Tam, C. S.; Kamel, S.; ; Haematologica; 2016-3-1 https://doi.org/10.3324/haematol.2015.139030
Summary[edit | edit source]
Note: Opened to append information.